MNPR earnings
Monopar Therapeutics (MNPR) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- MNPR beat EPS estimates in 11 of its last 17 reports.
MNPR earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 12, 2026 | -0.72 | -0.72 | -0.53% | – |
| Q2 2026 | Aug 12, 2026 | -0.62 | -0.64 | 3.64% | – |
| Q1 2026 | May 14, 2026 | -0.46 | -1.06 | 56.60% | – |
| Q4 2025 | Mar 27, 2026 | -0.61 | -0.51 | -19.08% | – |
| Q3 2025 | Nov 13, 2025 | -0.48 | -0.46 | -4.35% | – |
| Q2 2025 | Aug 12, 2025 | -0.35 | -0.47 | 25.53% | – |
| Q1 2025 | May 13, 2025 | -0.38 | -0.65 | 41.54% | – |
| Q4 2024 | Mar 31, 2025 | -2.23 | -0.36 | -519.44% | – |
| Q3 2024 | Nov 8, 2024 | -0.37 | -0.46 | 19.57% | – |
| Q2 2024 | Aug 9, 2024 | -0.50 | -0.45 | -11.11% | – |
| Q1 2024 | May 9, 2024 | -0.50 | -0.85 | 41.18% | – |
| Q4 2023 | Mar 28, 2024 | -0.60 | -0.85 | 29.41% | – |
| Q3 2023 | Nov 9, 2023 | -0.70 | -0.95 | 26.32% | – |
| Q2 2023 | Aug 10, 2023 | -0.80 | -0.95 | 15.79% | – |
| Q1 2023 | May 11, 2023 | -0.95 | -1.00 | 5.00% | – |
| Q4 2022 | Mar 23, 2023 | -1.10 | -1.05 | -4.76% | – |
| Q3 2022 | Nov 10, 2022 | -0.95 | -1.15 | 17.39% | – |